Sumary of FDA and CDC Lift Pause of J&J COVID-19 Vaccine Due to Rare Blood-Clot Cases:
- Johnson COVID-19 vaccine, the government agencies announced that the benefits of the vaccine outweigh the rare risk of blood clotting..
- Since the initial pause, there have been 15 reported blood-clot cases out of almost eight million administered vaccine doses;.
- all occurred in women between the ages of 18 and 59 (most were under 50) with symptoms beginning between six and 15 days postvaccination..
- Three women have died and seven remained in the hospital as of April 23, according to the Associated Press, and The New York Times reported that 12 of these women developed blood clots in the brain specifically….